Skip to content
DataLookout
Menu

RESO101NCT07602426

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of resO™ Bone and Joint Support Postbiotic on Physical Function, Pain Interference, and Mobility in Adults With Joint Discomfort

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below.

  1. Minor Trial completed
    • Primary completion date changed from estimate of May 15, 2026 to Jun 2, 2026
    • Study completion date changed from estimate of May 31, 2026 to Jun 2, 2026
    • Secondary endpoints: details revised at 2 of 3 entries
  2. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

Change From Baseline to Week 4 in PROMIS Physical Function T-score
Timeframe: Baseline and Week 4
Changes in gut microbiota composition associated with bone health
Timeframe: 8 weeks
Change From Baseline to Week 4 in PROMIS Pain Interference T-score
Timeframe: Baseline and Week 4

Secondary (3)

Change From Baseline to Week 4 in Pain Intensity Numeric Rating Scale (NRS) Score
Change From Baseline to Week 4 in Duke Activity Status Index (DASI) Score
Change From Baseline to Week 4 in International Physical Activity Questionnaire-Short Form (IPAQ-SF) MET-minutes/week

Arms and interventions

PlaceboPlacebo comparator
SupplementExperimental

Other: Placebo

Dietary supplements: Supplement

Sites

1 site in 1 country

  • Able Biolabs LLCDallas, Texas, United States